This study examined the utility of a screening battery developed by Reitan & Wolfson, 2006 for predicting neuropsychological impairment on the Halstead-Reitan neuropsychological test battery for adults. Using archival neuropsychological data from 69 litigants seen in a private practice setting, the Pearson correlation between the General Neuropsychological Deficit Scale (GNDS) score and the total Neuropsychological Deficit Scale (NDS) score from the screening battery (SBNDS) was .82. ROC curve analysis determined that the AUC was .88. Using a cutoff score of 9, as recommended by Reitan and Wolfson, the screening battery had excellent specificity but only fair sensitivity for identifying individuals with neuropsychological impairment on the Halstead-Reitan battery. Using a cutoff score of 8, the sensitivity and specificity of the screening battery was comparable to the findings of Reitan and Wolfson. The findings from this study indicate the optimal cutoff score for the screening battery may vary with different populations. The positive predictive power (PPP) and negative predictive power (NPP) were calculated for various base rates for cut scores with both sensitivity and specificity of greater than .600, and this information is provided. © 2008 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.
regarding the "next step" once possible impairment is identified. Of those screening batteries researched, neither the Mini-Mental State Exam (MMSE), the Neurobehavioral Cognitive Status Examination (NCSE), nor the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) specifies a subsequent course of action when examinees score within a certain range on the screening test. Additionally, ROC analysis performed on the MMSE and NCSE has suggested that regardless of cutoff score used, neither instrument yields an acceptable balance between sensitivity and specificity when used with geriatric patients (Roper et al., 1996) . While the Neuropsychological Assessment Battery-Screening Module (NAB-SM) does specify how the clinician is to proceed based on how the patient scores on the screening module, this is a relatively new instrument currently lacking in a well-established body of literature.
Recently, Reitan and Wolfson (2006) introduced screening batteries that are intended to be used to identify individuals who require a comprehensive neuropsychological evaluation. They have developed separate screening batteries for younger children, older children, and adults; these batteries are comprised of tests from the Reitan-Indiana neuropsychological test battery, Halstead-Reitan neuropsychological test battery for older children, and the Halstead-Reitan neuropsychological test battery for adults, respectively. Each screening battery is completed in two phases, with the first phase comprised of a single test that requires minimal time to administer and serves to identify individuals who should be administered the full screening battery. Reitan and Wolfson have developed guidelines for determining when the full screening battery should be administered, and when a comprehensive neuropsychological evaluation should be completed. The guidelines are based upon studies they completed with groups of individuals with medically confirmed brain damage. In addition, Reitan and Wolfson have examined the correlations between scores on their screening batteries and total scores of the respective batteries from which each was derived.
Given that these are recently introduced screening batteries, additional research on the predictive validity of each measure is needed. In this study, we were interested in examining the predictive validity of the screening battery for adults in a sample of individuals referred for neuropsychological evaluation in the context of litigation. While Reitan and Wolfson use a two-phase procedure, we considered the complete screening battery only in examining the relationship between performance on the screening battery and performance on the full Halstead-Reitan neuropsychological test battery (HRNB) for adults.
Method

Participants
Approval for analysis of archival data was obtained from a human subjects institutional review board. Of 110 participants initially evaluated in a private practice setting while pursuing litigation as a result of experienced head trauma, 30 were excluded from the study due to failing the Test of Memory Malingering (TOMM; Tombaugh, 1996) , a symptom validity measure designed to determine effort, one was excluded due to not being administered the TOMM, and 10 were excluded due to missing data necessary to perform the analyses. Of the remaining 69 participants included in the study, 62% were male and 88% were right-handed; all were Caucasian. These participants ranged in age from 
Instruments and procedure
General Neuropsychological Deficit Scale (GNDS) scores were computed for each participant using 42 variables from the HRNB (see Reitan & Wolfson, 1993) . Total Neuropsychological Deficit Scale (NDS) scores for the screening battery (SBNDS) were then computed for each participant by converting raw scores from seven variables from the four subtests. These seven variables include: time on Trail Making Test-Part A (TMT-A); time on Trail Making Test-Part B (TMT-B); total time and right/left differences on Tactile Form Recognition Test (TFRT); number of dominant hand taps, number of nondominant hand taps, and right/left differences on Finger Tapping Test (FTT). For each of these variables, raw scores were converted into scores ranging from 0 (normal range) to 3 (severe impairment). See Wolfson (1993, 2006) for a fuller description.
Analyses
One main goal of this study was to determine how well participants' scores on a proposed screening battery from the HRNB correlated with those from the full battery. To achieve this aim, the correlation between GNDS and SBNDS scores was determined, and a logistic regression was performed to ascertain correct classification rates for normal and impaired participants. Additionally, in order to obtain a picture of how well the screening battery detects impairment independent of base rate and decision threshold, a receiver operating characteristic (ROC) curve analysis was performed. Another chief goal of the present study was to cross-validate those findings from Reitan and Wolfson (2006) . These authors suggest that a score of 9 on the screening battery should prompt recommendation for a comprehensive neuropsychological evaluation, while a score of 10 serves as a clearer indication that a comprehensive neuropsychological evaluation is needed. In this study, we initially used a cutoff score of 9 in determining the sensitivity, specificity, positive predictive power (PPP), and negative predictive power (NPP) of the screening battery. However, given potential differences between samples and different clinician needs regarding the balance between sensitivity and specificity, these predictive utility values were subsequently calculated for other scores as well. Finally, in order to provide useful information for clinicians in a variety of settings, PPP and NPP were calculated for a variety of base rates at those cutoff scores which yielded both sensitivity and specificity values of greater than .600.
Results
The Pearson correlation between the GNDS and SBNDS scores was .82 (p ≤ .01). Using logistic regression to determine how well SBNDS scores (used as a continuous variable) correctly classified participants as either in the normal range (as indicated by a GNDS score of 25 or less, as suggested by Reitan and Wolfson (1993) ) or impaired (GNDS ≥ 26), we found that 78.6% of normal participants were correctly classified as such while 82.9% of impaired participants were correctly classified. The overall correct classification rate was 81.2%.
An ROC curve was subsequently generated (see Fig. 1 ), and the area under the curve (AUC) was determined to be .882 (S.E. = .041), suggesting an 88.2% chance that a randomly chosen impaired individual will have test scores exceeding those of a randomly chosen unimpaired individual at every threshold (Murphy et al., 1987) . Larger AUC is associated with higher classification accuracy (Gallop, Crits-Christoph, Muenz, & Tu, 2003) , and an AUC of between .80 and .89 is considered "good" according to convention (Sideridis, Morgan, Botsas, Padeliadu, & Fuchs, 2006) . Additionally, the AUC we calculated may actually be an underestimate of the actual AUC given that conservative nonparametric methods were used to obtain the statistic (Hanley & McNeil, 1982) . This AUC was found to be significantly different from the line of no information (p < .001), which runs diagonally from the lower left corner to the upper right corner of the graph and predicts at the chance level. Some researchers have suggested that AUC is the most useful index of the ability of a screening battery to discriminate between conditions (Mari & Williams, 1986) . The predictive utility of the screening battery was also investigated by calculating the sensitivity, specificity, PPP, and NPP. Participants' score patterns were first classified using GNDS scores of 26 or greater as indicative of true impairment and SBNDS scores of 9 or greater as suggestive of probable impairment on the GNDS, as recommended by Reitan and Wolfson (2006) . Using these cutoffs, participants were classified as true negatives (normal GNDS and SBNDS scores; n = 27), true positives (impaired GNDS and SBNDS scores; n = 29), false negatives (impaired GNDS and normal SBNDS scores; n = 12), or false positives (normal GNDS and impaired SBNDS scores; n = 1) (see Table 1 ). Using the aforementioned classifications, the battery was found to have a sensitivity of 71% and a specificity of 96%. The PPP of the screening battery was determined to be .97, suggesting that if the screening battery predicts impairment, there is a 97% likelihood that the participant will be deemed impaired on the full HRNB. The NPP of the screening battery was found to be .69, signifying a 69% chance that a participant deemed normal on the basis of the screening battery will be unimpaired on the full HRNB. PPP and NPP may be considered more important factors than sensitivity and specificity in determining the predictive utility of a test, as these factors account for base rates (Elwood, 1993) .
Although the screening battery yielded excellent specificity and fair sensitivity in our sample using a cutoff score of 9, we were somewhat concerned about the high number of false negatives. Therefore, in order to further examine the profiles of these cases, we grouped them by level of impairment (normal range, mild impairment, moderate impairment, severe impairment), as indicated by GNDS score (Reitan & Wolfson, 1993) . Of the 12 false negatives, 10 fell in the mildly impaired range (GNDS score of 26-40), 2 fell in the moderately impaired range (GNDS score of 41-67), and none fell in the severely impaired range (GNDS score of 68 or greater; see Table 2 ). Adjusting the cutoff score to 8 resulted in 5 fewer false negatives, including 1 of the moderately impaired cases. In order to further investigate the predictive utility of various cutoff scores, sensitivity, specificity, PPP, and NPP were calculated for cutoff scores from 3 through 10 (see Table 3 ), with a cutoff score of 3 being the highest score to yield a sensitivity of 1.000 and a cutoff score of 10 the lowest score to yield a specificity of 1.000. Stated differently, no individual deemed impaired on the full Note: PPP, positive predictive power and NPP, negative predictive power. Note: PPP, positive predictive power and NPP, negative predictive power.
HRNB had an SBNDS of less than 3, while no individual scoring in the normal range on the HRNB had an SBNDS of greater than 10. Examination of these data suggest that a cutoff score of 8 may indeed be preferable to that of 9 in this sample in order to increase the sensitivity of the screening battery. However, in order to make better and more informed decisions regarding optimal cut scores, the base rate of impairment in the population in which a clinician practices must also be taken into account. Therefore, PPP and NPP were calculated for five different prevalence rates at those cut scores with both sensitivity and specificity of greater than .600 (see Table 4 ). Examination of this table suggests that different cut scores may be optimal in different populations. For instance, a clinician practicing in a setting in which the base rate of impairment is only 2% may wish to use a higher cut score in order to reduce the probability of obtaining false positive results. Changing the cut score from 7 to 10, for example, increases PPP by .956 while only reducing NPP by .004. For another clinician practicing in a setting with a 75% prevalence of impairment, however, a lower cut score may be best in order to reduce the chances of obtaining false negative results. In this instance, changing the cut score from 10 to 8 would increase NPP by .134 while only reducing PPP by .079.
Discussion
One purpose of this study was to cross-validate the findings from Reitan and Wolfson (2006) . Although the rates of correct classification obtained in the present study were relatively high, the pattern was opposite that found by Reitan and Wolfson; using the same cut score of 9 in both samples, the screening battery better classified unimpaired than impaired individuals in our sample, whereas the reverse was true in the Reitan and Wolfson sample. Using a cutoff score of 9 or above, Reitan and Wolfson found the screening battery to have a sensitivity of 88% and a specificity of 74%. In our study, this cutoff score resulted in a sensitivity of 71% and a specificity of 96%. Using a cut score of 8 in our sample, which may be justified given the higher base rate of impairment in our sample (59.4% vs. 50.0%) and the resulting reduction in false negatives, sensitivity (83%) and specificity (79%) were more comparable to those found by Reitan and Wolfson. It is important to note that the methodology utilized in the two studies was different. Whereas in the present study SBNDS scores were compared with GNDS scores from the full HRNB in order to determine correct classification rates, in the Reitan and Wolfson study, SBNDS scores were compared with diagnosis status (i.e., no past or present evidence of brain damage or disease, or diagnosis of brain damage or disease, prior to study enrollment). A main benefit of our methodology is that some determination of base rate within the population from which the sample is derived can be made. However, the information we used in judging "true" impairment (i.e., the full HRNB) was not completely independent from that provided by the screening battery. While correction of the validity coefficients for overlapping error variance is necessary when determining the degree to which subtests from a full battery (e.g., short form/screening battery) and the full battery measure the same construct, it is not necessary when the purpose of the analysis is to determine the utility of a screening battery for identifying individuals who should be administered the full battery (Kaufman, 1977) .
It should also be noted that no participants in our study fell into the severely impaired range on the full HRNB. Although this suggests that our results may not be generalized to severely impaired individuals, it may also be viewed as an indication of the strength of our findings, as severely impaired individuals are likely to perform most poorly on the screening battery as well as on the full HRNB. Finally, findings from our research provide information regarding the predictive utility of Reitan and Wolfson's screening battery for Caucasian adults with a history of head trauma who were involved in litigation associated with the head trauma. Further study of the predictive validity of this screening battery with other samples should be completed to further validation with a general clinical sample.
Overall, the findings from this study serve as further validation of the use of Reitan and Wolfson's screening battery for identifying adults who need a more comprehensive neuropsychological assessment to assess for the presence of cerebral impairment. A comprehensive neuropsychological evaluation also provides an understanding of the individual's neuropsychological strengths and weaknesses, which is essential for planning treatment and determining functional capabilities.
As a final note, an exclusionary criterion for participation in this study was failure on symptom validity testing. In this study, those participants who failed the TOMM were considered to have put forth incomplete effort and were not included in the analyses. Of those 30 initial participants, GNDS and SBNDS scores were able to be calculated for 22 individuals. Of these 22, 18 were deemed true positives, two false negatives, one true negative, and one false positive. Preliminary analyses suggested that none of the individual subtests comprising the screening battery were able to predict performance on the TOMM. The finding that the majority of those participants failing the TOMM were deemed impaired on both the screening battery and the full HRNB serves as an illustration of the need to conduct symptom validity testing, particularly when evaluating individuals involved in litigation, in order to obtain a fuller picture of the individual's level of effort.
